TD Cowen Short Interest Report – Life Sciences (as of July 15, 2026)
TD Cowen released short‑interest data for the life‑science and diagnostic‑tools industry covering positions as of 15 July 2026. The report identifies MDxHealth (NASDAQ:MDXH) with a short‑interest increase of 1.34 %, Bruker Corporation (NASDAQ:BRKR) with a 0.17 % rise, Illumina (NASDAQ:ILMN) showing a 2.21 % increase, and NeoGenomics (NASDAQ:NEO) listed among the top gainers despite the accompanying table indicating a –4.18 % change.
Conversely, Bio‑Techne (NASDAQ:TECH) recorded a 0.17 % decline, Tempus AI (NASDAQ:TEM) fell by 0.07 %, Natera (NASDAQ:NTRA) decreased by 1.23 %, and CAI International was noted as one of the stocks with the largest short‑interest reductions.
The four most heavily shorted names in the sector were Whole Genome Sequencing (NASDAQ:WGS) with a 2.94 % increase in short interest, Grail (NASDAQ:GRAL) down 0.40 %, Tempus AI (NASDAQ:TEM) down 0.07 %, and Pacific Biosciences (NASDAQ:PACB) up 0.37 %.
These figures reflect the shifting short‑selling sentiment across the life‑science space as captured by TD Cowen’s latest data release.